Completed Picks

Topline Results by Round

Each tile shows sponsor movement from three trading days before an event through three trading days after.

View Active Picks

Round 3 Picks

1 Completed

HUTCHMED (China) Limited

Ticker: HCM

Drug: ORPATHYS (savolitinib) and TAGRISSO (osimertinib) - (SANOVO)

Disease: First-line treatment in certain non-small cell lung cancer (NSCLC)

Topline Date: September 1, 2026

Outcome: PASS

-3.0% from 3 days before to 1 day after

Round 2 Picks

5 Completed

Alumis Inc.

Ticker: ALMS

Drug: ESK-001

Disease: Plaque psoriasis

Topline Date: January 6, 2026

Outcome: PASS

+100.4% from 3 days before to 3 days after

Xenon Pharmaceuticals

Ticker: XENE

Drug: Azetukalner (XEN1101)

Disease: Adult focal epilepsy (focal-onset seizures)

Topline Date: March 9, 2026

Outcome: PASS

+34.5% from 3 days before to 3 days after

Cytokinetics Incorporated

Ticker: CYTK

Drug: Aficamten (CY 601)

Disease: Non-obstructive hypertrophic cardiomyopathy (nHCM)

Topline Date: May 5, 2026

Outcome: PASS

+20.2% from 3 days before to 3 days after

oculis

Ticker: OCUL

Drug: OCS-01 (dexamethasone ophthalmic)

Disease: Diabetic macular edema (DME)

Topline Date: May 28, 2026

Outcome: FAIL

+8.5% from 3 days before to 2 days after

Alumis Inc.

Ticker: ALMS

Drug: EryDex (intra-erythrocyte dexamethasone)

Disease: Ataxia-telangiectasia (A-T)

Topline Date: March 30, 2026

Outcome: PASS

-5.8% from 3 days before to 3 days after

Round 1 Picks

8 Completed

Abivax S.A.

Ticker: ABVX

Drug: Obefazimod - (ABTECT)

Disease: Ulcerative colitis

Topline Date: July 22, 2025

Outcome: PASS

+543.0% from 3 days before to 3 days after

DBV Technologies

Ticker: DBVT

Drug: Viaskin Peanut - (VITESSE)

Disease: Peanut allergy

Topline Date: December 17, 2025

Outcome: PASS

+10.3% from 3 days before to 3 days after

Kymab Limited purchased by Sanofi

Ticker: SNY

Drug: Amlitelimab (KY1005) - (STREAM-AD)

Disease: Atopic dermatitis

Topline Date: March 28, 2026

Outcome: PASS

+4.0% from 3 days before to 3 days after

AbbVie

Ticker: ABBV

Drug: RINVOQ (upadacitinib)

Disease: Non-segmental vitiligo (NSV)

Topline Date: July 30, 2025

Outcome: PASS

+3.6% from 3 days before to 3 days after

Levo Therapeutics, Inc. (aquired by ACADIA Pharmaceuticals Inc)

Ticker: ACAD

Drug: Carbetocin (ACP-101) - (COMPASS PWS)

Disease: Prader-Willi syndrome (PWS)

Topline Date: September 24, 2025

Outcome: FAIL

-12.7% from 3 days before to 3 days after

Soligenix

Ticker: SNGX

Drug: HyBryte - (FLASH2)

Disease: Cutaneous T-Cell Lymphoma

Topline Date: April 28, 2026

Outcome: FAIL

-75.2% from 3 days before to 3 days after

Gossamer Bio, Inc

Ticker: GOSS

Drug: Seralutinib (GB002) - (TORREY/PROSERA)

Disease: Pulmonary arterial hypertension (PAH)

Topline Date: February 23, 2026

Outcome: FAIL

-81.6% from 3 days before to 3 days after

Pherin Pharmaceuticals, Inc. acquired by Vistagen (Nasdaq: VTGN) i

Ticker: VTGN

Drug: PH94B - (PALISADE-4)

Disease: Social Anxiety Disorder (SAD)

Topline Date: December 17, 2025

Outcome: FAIL

-82.4% from 3 days before to 3 days after